Clinical Trials in Massachusetts

Showing 2621-2640 of 8,511 trials

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

NCT05971381

To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.

Avita Medical109 participantsStarted Aug 2023

Scottsdale, Arizona, United States • Irvine, California, United States • San Diego, California, United States +14 more locations

RECRUITINGPhase 221 miles

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

NCT06810050

The goal of this clinical trial is to learn if CGB-500 works to treat atopic dermatitis in participants ages 12 and older. The goal is also to learn about the safety of CGB-500. The main questions it aims to answer are: Does CGB-500 improve atopic dermatitis by decreasing the area affected and the severity of the lesions? What medical problems do participants have when taking CGB500? Researchers will compare CGB-500 to a placebo (a look-alike substance that contains no drug) to see if CGB-500 works to treat atopic dermatitis. Participants will: Take CGB-500 or a placebo every day for 8 weeks. Visit the clinic once every 2 weeks for the first month and at the end of 8 weeks. Keep a diary of when they use the product and complete a form about their symptoms including itching.

Atopic Dermatitis (AD)

CAGE Bio Inc.180 participantsStarted Dec 2024

Fremont, California, United States • Manhattan Beach, California, United States • San Diego, California, United States +13 more locations

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Find Trials by Condition in Massachusetts

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders

Detection of Small Fiber Neuropathy Using Skin Properties

Comparative Effectiveness of Operative Versus Non-Operative Treatments for Rotator Cuff Tears

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

Improving Detection and Early Action for HPV-positive Oropharynx Cancer

Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

Vascularized Composite Allotransplantation for Multiple Extremity Amputations

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Different Doses of Naronapride Vs. Placebo in Gastroparesis

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements